-
Needham Slashes Revenue, Earnings Projections, Price Targets of Majority Semiconductor Stocks: Key Takeaways
Tuesday, July 5, 2022 - 3:03pm | 554Needham analyst N. Quinn Bolton saw a slowdown in demand across most end markets coupled with several quarters of inventory purge is likely to significantly decrease semiconductor sales in C2H22 and 2023 from original base case estimates. His data analysis and other macro influences...
-
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
Wednesday, May 4, 2022 - 10:21am | 300Masimo Corp's (NASDAQ: MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700...
-
Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales
Thursday, March 31, 2022 - 12:16pm | 272Masimo Corp (NASDAQ: MASI) expects Q1 FY22 product revenue of $285 million - $315 million, lower than expected. Shortages of critical components and other supply chain issues, including freight carrier delays, have led to lower-than-expected sales in the first quarter. Related: Joe...
-
10 Biggest Price Target Changes For Thursday
Thursday, March 31, 2022 - 9:41am | 408Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday. Canaccord Genuity cut Motorsport Games Inc. (NASDAQ: MSGM) price target from $12 to $5. Motorsport Games shares fell 27.2% to $1....
-
Needham Upgrades Masimo To Buy, With Price Target Of $205
Friday, February 18, 2022 - 9:40am | 241Needham has upgraded Masimo Corp (NASDAQ: MASI) to Buy from Hold with a $205 price target. According to analyst Mike Matson, the selloff in the stock following the company's Sound United acquisition was "overdone" as the deal should prove to be highly...
-
56 Biggest Movers From Yesterday
Thursday, February 17, 2022 - 5:14am | 2005Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral immunotherapy as a component of a potential functional curative regimen for human immunodeficiency...
-
Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher
Wednesday, February 16, 2022 - 2:32pm | 796US stocks pared losses toward the end of trading on Wednesday following the release of Fed minutes. The Dow traded down 0.09% to 34,957.54 while the NASDAQ fell 0.17% to 14,115.37. The S&P, however, gained 0.15% to 4,477.98. Check out this: Insiders Buy More Than $18M Of 4 Stocks Leading and...
-
Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories
Wednesday, February 16, 2022 - 12:06pm | 829US stocks traded lower midway through trading on Wednesday ahead of the release of Fed minutes. The Dow traded down 0.59% to 34,783.36 while the NASDAQ fell 0.92% to 14,009.57. The S&P also fell, dropping, 0.52% to 4,447.84. Check out this: Insiders Buy More Than $18M Of 4 Stocks Leading and...
-
40 Stocks Moving In Wednesday's Mid-Day Session
Wednesday, February 16, 2022 - 12:01pm | 1468Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral immunotherapy as a component of a potential functional curative regimen for human immunodeficiency virus (HIV). Upstart...
-
Mid-Morning Market Update: Markets Open Lower Ahead Of Fed Minutes
Wednesday, February 16, 2022 - 10:09am | 880US stocks opened on a downbeat note this morning following the release of several economic reports. Following the market opening Wednesday, the Dow traded down 0.57% to 34,789.78 while the NASDAQ fell 1.32% to 13,953.73. The S&P also fell, dropping, 0.76% to 4,437.27. Check out this: Insiders...
-
Masimo Stock Plunges After Q4 Results, Sound United Deal
Wednesday, February 16, 2022 - 8:41am | 319Masimo Corp's (NASDAQ: MASI) Q4 product revenue increased 11% Y/Y to $327.6 million, or 11.5% on a constant currency basis, beating the consensus of $320.93 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 76,...
-
10 Biggest Price Target Changes For Wednesday
Wednesday, February 16, 2022 - 7:23am | 414Needham raised Airbnb, Inc. (NASDAQ: ABNB) price target from $210 to $220. Airbnb shares rose 3.1% to $185.70 in pre-market trading. Piper Sandler lowered the price target for Masimo Corporation (NASDAQ: MASI) from $330 to $200. Masimo shares fell 6.1% to $215.00 in pre-market trading. Goldman...
-
10 Biggest Price Target Changes For Tuesday
Tuesday, December 28, 2021 - 8:23am | 388Argus Research raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,010 to $1,313. Tesla shares rose 1.8% to $1,113.84 in pre-market trading. Needham boosted the price target for Ciena Corporation (NYSE: CIEN) from $80 to $88. Ciena shares rose 0.1% to $77.25 in pre-market trading. Stifel...
-
MACOM Transfers Minority Equity Stake In Ampere For $127.7M
Monday, December 27, 2021 - 10:55am | 199MACOM Technology Solutions Holdings Inc (NASDAQ: MTSI) completed the sale of its equity interest in Ampere Computing Holdings LLC to Denver Acquisition Corp for a predetermined cash consideration amount of ~$127.7 million. Ampere was established in 2017 when MACOM divested its ARM-...
-
3 Stocks Insiders Are Selling
Monday, November 29, 2021 - 7:58am | 456When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading...